cipla: Bain dials Dr Reddy's Laboratories to team up for joint Cipla bid
Private equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddys Laboratories (DRL) to explore a joint bid for the promoters of Cipla, the Hamied family. DRL is evaluating the opportunity and countering an offer from Torrent Pharma, another Indian investor. If DRL decides to participate, the combined entity would become the leading Indian-origin pharma major at home and in the US and emerging markets.
Source: indiatimes.com